03/10/2026 | Short News
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is joining the global community to mark World Kidney Day on March 12 and National Kidney Month in the U.S. throughout March. These annual observances highlight the ## Article Body 03/10/2026 | Short News Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is joining the global community to mark World Kidney Day on March 12 and National Kidney Month in the U.S. throughout March. These annual observances highlight the importance of kidney health, early detection, and education to help reduce the risk of chronic kidney disease (CKD). Often referred to as a “silent condition,” kidney disease can progress with few or no symptoms in its early stages. Millions of people worldwide are living with CKD, many without knowing it. As a trusted leader in kidney care, Fresenius Medical Care supports people affected by kidney disease every day through patient‑centered care, innovation, and education. To celebrate National Kidney Month in the U.S., Fresenius Kidney Care is unveiling a reimagined kidney care education program. This clinically approved curriculum is designed to support people with kidney disease, and their loved ones, at every stage of the journey. The program features dynamic, on-demand video modules that allow participants to tailor their learning experience. Individuals can explore topics most relevant to their needs, whether they are newly diagnosed, working to slow progression, or exploring treatment options. Each module delivers practical, real-world guidance in a supportive and empowering way. Every kidney journey is unique, and education should be, too. Which is why the experience will be available in both self-paced and small group, facilitator-led formats, providing flexibility to meet individual preferences. Throughout March, Fresenius Medical Care will continue to spotlight kidney health education, awareness, and resources for patients, caregivers, employees, and communities around the world. Learn more and watch our clinicians discuss what you should know about kidney disease here. Back To top: ## Recent Company News - 2026-07-29 07:00 EST — [Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients](https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-beacon-us-generating-real-world-evidence-suppor-8547f5f8) — Source: Fresenius Medical Care Ventures - 2026-07-20 07:00 EST — [Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy](https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a) — Source: Fresenius Medical Care Ventures - 2026-06-10 07:00 EST — [Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model](https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86) — Source: Fresenius Medical Care Ventures - 2026-06-03 07:00 EST — [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis) — Source: Fresenius Medical Care Ventures - 2026-05-28 07:00 EST — [Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million) — Source: Fresenius Medical Care Ventures ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)